Tag: Creatine kinase

While psychiatric medications like antipsychotics are known risk factors for rhabdomyolysis, the link is complex [1.2.1]. Although considered rare, case reports suggest an important question for patient safety: Can risperidone cause rhabdomyolysis, a condition of severe muscle breakdown? [1.3.5]

While considered a rare adverse effect, (

Among patients admitted for rhabdomyolysis, a condition of severe muscle breakdown, 10.5% are found to be taking an antipsychotic medication [1.5.1]. The question remains: **can Haldol cause rhabdomyolysis?** This article examines the association, mechanisms, and clinical implications.

Statin-induced autoimmune myositis is a rare condition with an estimated prevalence of 1 in 100,000 people [1.3.2]. A wide range of drugs beyond statins can also lead to muscle inflammation. Understanding what medication causes myositis is key to diagnosis and management.

While extremely rare, the incidence of hospitalized rhabdomyolysis for patients on statin monotherapy is about 0.44 per 10,000 person-years [1.2.1]. The critical question remains for many patients: **can cholesterol medication cause rhabdomyolysis**, and what are the risks?

Fenofibrate is a widely prescribed medication for managing high triglycerides and mixed dyslipidemia [1.4.4]. A key question for patients and clinicians is, **Can fenofibrate increase CK?** Yes, fenofibrate can cause an increase in creatine phosphokinase (CK), though significant elevations are less common [1.4.3, 1.3.1].

In a 2014 study published in *Nature*, researchers found that high levels of creatine kinase, an enzyme associated with creatine metabolism, could reduce platelet aggregation in a dose-dependent manner. This finding raises the question: **Can creatine affect platelets** in people who use this popular supplement? While the link is not direct, understanding the indirect mechanisms and reported side effects is crucial for safe supplementation practices.